中体产业：2025年前三季度净利润约-2107万元

Group 1 - Company Zhongti Industry reported Q3 performance on October 24, indicating revenue of approximately 1.244 billion yuan for the first three quarters of 2025, a year-on-year decrease of 19.95% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 21.07 million yuan [1] - Basic earnings per share showed a loss of 0.022 yuan [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market being active while the primary market faces challenges in fundraising [1]